Literature DB >> 6411824

Vaccine potential of meningococcal group C polysaccharide-tetanus toxoid conjugate.

E C Beuvery, F Miedema, R W van Delft, J Haverkamp, R H Tiesjema, J Nagel.   

Abstract

The antibody response in mice to Neisseria meningitidis (meningococcal) group C polysaccharide could be modified by its conjugation to proteins, i.e. tetanus toxoid. Whereas the pure polysaccharide behaved as a T-independent antigen, the polysaccharide-protein conjugate was clearly a T-dependent antigen, as shown by the pronounced IgG response after the first dose and by the booster effect after the second dose. In comparison, group C polysaccharide-outer membrane protein complexes isolated from the cell-free culture liquid of a meningococcal culture induced only a low level of IgG antibodies. Conjugation did not result in a reversion of tetanus toxoid to toxin. Tetanus toxoid present in the conjugate was as immunogenic as tetanus vaccine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411824     DOI: 10.1016/s0163-4453(83)93645-9

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

Review 1.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Mortality from group C meningococcal disease: a case for a conjugate vaccine?

Authors:  F A Riordan; O Marzouk; A P Thomson; J A Sills; C A Hart
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

Review 3.  The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?

Authors:  Martin C J Maiden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 4.  A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine.

Authors:  Yara Ruiz Garcia; Véronique Abitbol; Michele Pellegrini; Rafik Bekkat-Berkani; Lamine Soumahoro
Journal:  Infect Dis Ther       Date:  2022-04

Review 5.  Why might regional vaccinology networks fail? The case of the Dutch-Nordic Consortium.

Authors:  Jan Hendriks; Stuart Blume
Journal:  Global Health       Date:  2016-07-07       Impact factor: 4.185

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.